Anti-CD3 antibodies and uses thereof | Patent Publication Number 20200048349
US 20200048349 A1Patent NumberUS 11603405 B2
Application Number16418082
Filled DateMay 21, 2019
Priority DateMay 24, 2018
Publication DateFeb 13, 2020
Original AssigneeJohnson & Johnson
Current AssigneeJanssen Biotech Inc.
Inventor/ApplicantsRonan MCDAID
Bradley HEIDRICH
Ronan McDaid
Colleen Kane
Jennifer NEMETH-SEAY
Chichi Huang
Francois GAUDET
Jill Giles-Komar
Francois Gaudet
Chichi HUANG
Jill GILES-KOMAR
Jennifer Nemeth-Seay
Colleen KANE
Bradley Heidrich
Bradley HEIDRICH
Ronan McDaid
Colleen Kane
Jennifer NEMETH-SEAY
Chichi Huang
Francois GAUDET
Jill Giles-Komar
Francois Gaudet
Chichi HUANG
Jill GILES-KOMAR
Jennifer Nemeth-Seay
Colleen KANE
Bradley Heidrich
See the invalidated claims, subscribe to our Concierge Program.
View Concierge Program![Patent Prosecution report image](/_next/image?url=https%3A%2F%2Fpatexia-data.s3.amazonaws.com%2Fconnect%2F65256ba2e3fa03282001bdac%2F280_c4899fec3f1140f6f1ec05c01211cc01.jpg&w=384&q=75)
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.